Divergence or disorder?: the politics of naming intersex.

Women's and Gender Studies Program, 1298 University of Oregon, Eugene, OR 97403 USA.
Perspectives in biology and medicine (Impact Factor: 0.54). 02/2007; 50(4):535-43. DOI: 10.1353/pbm.2007.0054
Source: PubMed

ABSTRACT The conditions once known under the umbrella terms intersex and hermaphroditism are now generally being called disorders of sex development in medical settings. The terms might seem synonymous, but in fact there are significant differences with controversial consequences. Hermaphroditism, an older term that can still be found in many medical writings, is vague, demeaning, and sensationalistic, conjuring mythic images of monsters and freaks. In the 1990s, activists advocated intersex to describe discordance between the multiple components of sex anatomy, but that word alienated many parents of affected children, as it suggests a self-conscious alternative gender identity and sexuality. Disorders of sex development also refers to intersex, but it deemphasizes the identity politics and sexual connotations associated with intersex, avoids the degradation associated with hermaphrodite, and instead highlights the underlying genetic or endocrine factors that cause prenatal sex development to take an unusual path. I argue that using disorder is problematic, because it implies medical conditions in need of repair, when some intersex anatomies, though atypical, do not necessarily need surgical or hormonal correction. I advocate a less pathologizing new term, divergence of sex development, that might reduce some of the conflict over nomenclature and satisfy intersex people, their parents, and their doctors.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The prevalent policy is that 46, XX children born with congenital adrenal hyperplasia (CAH) should be assigned to the female sex given their potential reproductive capacity. The parsimonious argument is that the scarcity of long-term outcome studies with regard to gender identity and overall sexual health among these individuals does not warrant a moratorium to current medical practices. Nevertheless, new propositions suggest that clinical sex assignment at birth does not necessarily need to follow traditional biological criteria to define sex, such as karyotype, gonads, hormonal profile, and genital appearance. In agreement with a number of international organizations, the Caracas Consensus Group (2012) has taken the position that gender non-conformity among individuals born with genital variance can be an iatrogenic artifact. We present data on ten adolescent and adult 46, XX individuals with confirmed CAH diagnosis who were born, raised, and managed in Cuba or Puerto Rico. Given the lack of international agreement and based on long-term outcome data on gender expressions among 46, XX CAH individuals, we advocate for a Caribbean social policy that prioritizes the right to live gender as chosen by individuals born with genital variance.
    Sexuality Research and Social Policy: Journal of NSRC 09/2013; · 0.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mammalian sex determination is the unique process whereby a single organ, the bipotential gonad, undergoes a developmental switch that promotes its differentiation into either a testis or an ovary. Disruptions of this complex genetic process during human development can manifest as disorders of sex development (DSDs). Sex development can be divided into two distinct processes: sex determination, in which the bipotential gonads form either testes or ovaries, and sex differentiation, in which the fully formed testes or ovaries secrete local and hormonal factors to drive differentiation of internal and external genitals, as well as extragonadal tissues such as the brain. DSDs can arise from a number of genetic lesions, which manifest as a spectrum of gonadal (gonadal dysgenesis to ovotestis) and genital (mild hypospadias or clitoromegaly to ambiguous genitalia) phenotypes. The physical attributes and medical implications associated with DSDs confront families of affected newborns with decisions, such as gender of rearing or genital surgery, and additional concerns, such as uncertainty over the child's psychosexual development and personal wishes later in life. In this Review, we discuss the underlying genetics of human sex determination and focus on emerging data, genetic classification of DSDs and other considerations that surround gender development and identity in individuals with DSDs.
    Nature Reviews Endocrinology 08/2014; · 12.96 Impact Factor
  • Article: Transbutch
    TSQ: Transgender Studies Quarterly. 05/2014; 1(1-2):230-232.


Available from